341 related articles for article (PubMed ID: 32855285)
1. Deficits in verbal fluency in presymptomatic
Lulé DE; Müller HP; Finsel J; Weydt P; Knehr A; Winroth I; Andersen P; Weishaupt J; Uttner I; Kassubek J; Ludolph AC
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1195-1200. PubMed ID: 32855285
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
3. Network degeneration and dysfunction in presymptomatic
Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal diffusion imaging across the
Floeter MK; Danielian LE; Braun LE; Wu T
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):53-60. PubMed ID: 29054917
[TBL] [Abstract][Full Text] [Related]
5. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.
Querin G; Bede P; El Mendili MM; Li M; Pélégrini-Issac M; Rinaldi D; Catala M; Saracino D; Salachas F; Camuzat A; Marchand-Pauvert V; Cohen-Adad J; Colliot O; Le Ber I; Pradat PF;
Ann Neurol; 2019 Aug; 86(2):158-167. PubMed ID: 31177556
[TBL] [Abstract][Full Text] [Related]
6. Eye movement alterations in presymptomatic C9orf72 expansion gene carriers.
Behler A; Knehr A; Finsel J; Kunz MS; Lang C; Müller K; Müller HP; Pinkhardt EH; Ludolph AC; Lulé D; Kassubek J
J Neurol; 2021 Sep; 268(9):3390-3399. PubMed ID: 33709219
[TBL] [Abstract][Full Text] [Related]
7. Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study.
Wiesenfarth M; Huppertz HJ; Dorst J; Lulé D; Ludolph AC; Müller HP; Kassubek J
Neuroimage Clin; 2023; 39():103505. PubMed ID: 37696099
[TBL] [Abstract][Full Text] [Related]
8. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
[TBL] [Abstract][Full Text] [Related]
9. Disease progression in
Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T
Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433
[TBL] [Abstract][Full Text] [Related]
10. The involvement of language-associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations.
Tahedl M; Tan EL; Chipika RH; Lope J; Hengeveld JC; Doherty MA; McLaughlin RL; Hardiman O; Hutchinson S; McKenna MC; Bede P
Brain Behav; 2023 Nov; 13(11):e3250. PubMed ID: 37694825
[TBL] [Abstract][Full Text] [Related]
11. Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers.
Bede P; Lulé D; Müller HP; Tan EL; Dorst J; Ludolph AC; Kassubek J
J Neurol; 2023 Sep; 270(9):4235-4247. PubMed ID: 37178170
[TBL] [Abstract][Full Text] [Related]
12. Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
Saxon JA; Thompson JC; Harris JM; Richardson AM; Langheinrich T; Rollinson S; Pickering-Brown S; Chaouch A; Ealing J; Hamdalla H; Young CA; Blackburn D; Majeed T; Gall C; Jones M; Snowden JS
J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1304-1311. PubMed ID: 33055142
[TBL] [Abstract][Full Text] [Related]
13. Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers.
Nigri A; Stanziano M; Fedeli D; Manera U; Ferraro S; Medina Carrion JP; Palermo S; Lequio L; Denegri F; Agosta F; Spinelli EG; Filippi M; Grisoli M; Valentini MC; De Mattei F; Canosa A; Calvo A; Chiò A; Bruzzone MG; Moglia C
Eur J Neurol; 2024 Jun; 31(6):e16266. PubMed ID: 38469975
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
[TBL] [Abstract][Full Text] [Related]
15. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
16. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile.
Devenney E; Hornberger M; Irish M; Mioshi E; Burrell J; Tan R; Kiernan MC; Hodges JR
JAMA Neurol; 2014 Mar; 71(3):331-9. PubMed ID: 24445580
[TBL] [Abstract][Full Text] [Related]
17. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
[TBL] [Abstract][Full Text] [Related]
18. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.
Bertrand A; Wen J; Rinaldi D; Houot M; Sayah S; Camuzat A; Fournier C; Fontanella S; Routier A; Couratier P; Pasquier F; Habert MO; Hannequin D; Martinaud O; Caroppo P; Levy R; Dubois B; Brice A; Durrleman S; Colliot O; Le Ber I;
JAMA Neurol; 2018 Feb; 75(2):236-245. PubMed ID: 29197216
[TBL] [Abstract][Full Text] [Related]
19. In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study.
Müller HP; Del Tredici K; Lulé D; Müller K; Weishaupt JH; Ludolph AC; Kassubek J
Neuroimage Clin; 2020; 27():102298. PubMed ID: 32505118
[TBL] [Abstract][Full Text] [Related]
20. Cognition and gray and white matter characteristics of presymptomatic
Papma JM; Jiskoot LC; Panman JL; Dopper EG; den Heijer T; Donker Kaat L; Pijnenburg YAL; Meeter LH; van Minkelen R; Rombouts SARB; van Swieten JC
Neurology; 2017 Sep; 89(12):1256-1264. PubMed ID: 28855404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
